Sanofi Announces $20 Billion US Investment Plan Through 2030
French pharmaceutical giant Sanofi has committed to investing at least $20 billion in the United States by 2030, according to a Wednesday announcement. The funds will target expanded R&D capabilities and domestic manufacturing infrastructure.
The company’s 13,000 US employees currently lead development of first-in-class therapeutics across multiple disease areas. This planned capital injection aims to secure local production of critical medications as Sanofi prepares for potential launches of novel treatments.